Clinical Trials
2 trialsNCT00492167 2022-03-07
Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00037011 2013-01-18
Beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma
Memorial Sloan Kettering Cancer Center
Phase 1 Completed